Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancer - Concepedia

Concepedia

Publication | Open Access

Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancer

DOI Full Paper Access

93

Citations

21

References

2013

Year

Norihiro Yamaguchi, Antonio R. Lucena‐Araujo, Sohei Nakayama, Lorena Lôbo de Figueiredo-Pontes, David A. Gonzalez, Hiroyuki Yasuda, Susumu Kobayashi, Daniel B. Costa

Radiation OncologyEgfr InhibitionMedicineReceptor Tyrosine KinaseBronchial NeoplasmDual AlkOncologyCell BiologyLung Cancer

References

	Year	Citations

Page 1

Page 1